戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ence interval [95% CI], 0.26 to 0.43, versus radical nephrectomy).
2 clinical events in patients long after their radical nephrectomy.
3 improved renal function outcomes compared to radical nephrectomy.
4 itutions, with similar oncologic outcomes to radical nephrectomy.
5 the treatment of suspicious renal masses was radical nephrectomy.
6 as equivalent oncologic outcomes compared to radical nephrectomy.
7 ctomy and 5213 patients (73.0%) treated with radical nephrectomy.
8  risk of renal insufficiency associated with radical nephrectomy.
9 ectomy, and 222 patients (4.3%) treated with radical nephrectomy.
10 ons with cohorts of patients undergoing open radical nephrectomy.
11  renal cell carcinoma consists of partial or radical nephrectomy.
12  partial nephrectomy, but only 64% following radical nephrectomy.
13 er partial nephrectomy equals the results of radical nephrectomy.
14 therapy for most renal cancers involved open radical nephrectomy.
15 ll carcinoma from patients who had undergone radical nephrectomy.
16 h as renal mass biopsy or empiric partial or radical nephrectomy.
17 -clear cell histology planned for partial or radical nephrectomy.
18                               Of these, 4896 radical nephrectomy, 3508 partial nephrectomy, 13 327 ra
19 ts (84%) had known metastases at the time of radical nephrectomy (67% had lung metastases and 40% had
20 y include surgical resection with partial or radical nephrectomy, ablative techniques (eg, cryoablati
21 lth benefits of nephron sparing surgery over radical nephrectomy and its oncologic equivalency confir
22 ositive disease were randomly assigned after radical nephrectomy and lymphadenectomy to observation o
23  recent long-term oncological equivalence to radical nephrectomy and renal functional benefit, partia
24                          Patients undergoing radical nephrectomy are at an increased risk of noncance
25     Concurrent with the rise of laparoscopic radical nephrectomy as the gold standard for managing re
26   Partial nephrectomy may be as effective as radical nephrectomy as treatment for localized disease,
27  matched group of 125 patients who underwent radical nephrectomy at the same institution between 1986
28  Early-stage kidney cancer is treated with a radical nephrectomy, but under certain circumstances a p
29                       Nowadays, laparoscopic radical nephrectomy can be performed for pT2 tumors (up
30       CL activity was improved at 3 mo after radical nephrectomy compared with baseline, and it was a
31 redicts higher risk of progressive CKD after radical nephrectomy compared with the same percentage of
32  nephrectomy and 35% (28-43; p<0.0001) after radical nephrectomy; corresponding values for GFRs lower
33                                       Use of radical nephrectomy decreased over time (from 69.0% to 4
34 high risk renal cell carcinoma is partial or radical nephrectomy followed by surveillance.
35 ptable candidates for nephrectomy to undergo radical nephrectomy followed by therapy with interferon
36                Survival rates of partial and radical nephrectomies for patients with unilateral T1 RC
37 althy kidneys undergoing elective partial or radical nephrectomy for a solitary, renal cortical tumou
38            We studied patients who underwent radical nephrectomy for a tumor between 2000 and 2019.
39 nal parenchyma from patients who underwent a radical nephrectomy for a tumor over 2000-2015, and morp
40 utcomes, we studied patients who underwent a radical nephrectomy for a tumor.
41 ible adult patients had undergone partial or radical nephrectomy for histologically confirmed ccRCC a
42 e, partial nephrectomy for small tumours and radical nephrectomy for large tumours continue to be the
43 ical equations for estimating survival after radical nephrectomy for RCC.
44                         In patients electing radical nephrectomy for small renal masses, the kidney,
45   In circumstances, where patients elect for radical nephrectomy for small tumours, these kidneys sho
46                                              Radical nephrectomy for SRMs should only be reserved for
47  as an oncologically equivalent operation to radical nephrectomy for T1a tumors (<4 cm) with the adde
48 f laparoscopic radical nephrectomy over open radical nephrectomy for the majority of renal cell cance
49                       The overzealous use of radical nephrectomy for the T1 renal mass, by whatever s
50 idney donors and 1354 patients who underwent radical nephrectomy for tumor.
51 parenchyma from 812 patients who underwent a radical nephrectomy (for a tumor), separately characteri
52       A recent clinical trial of partial and radical nephrectomy found minimal differences in surviva
53 ge T1a kidney cancer treated with partial or radical nephrectomy from 1992 through 2007.
54                   The first case underwent a radical nephrectomy given the central location of the tu
55 chronic kidney disease in patients receiving radical nephrectomy have been associated with more nonca
56 sity of completing all the components of the radical nephrectomy have been questioned.
57 te better survival for patients treated with radical nephrectomy, have generated new uncertainty rega
58   The use of nephron-sparing surgery exceeds radical nephrectomy in patients who receive surgery.
59 nce and renal functional benefit compared to radical nephrectomy in select patients.
60 excellent long-term outcomes of laparoscopic radical nephrectomy in the form of retrospective compari
61 rectomy is becoming an alternate standard to radical nephrectomy in the management of T1b tumors.
62    The choice to either perform a partial or radical nephrectomy in these situations can be a challen
63 rd ratio, 0.15; 95% CI, 0.11 to 0.19, versus radical nephrectomy) in propensity score-matched cohorts
64                                              Radical nephrectomy is a significant risk factor for the
65 cent data support the prevailing notion that radical nephrectomy is associated with higher rates of c
66 rectomy has lagged behind while laparoscopic radical nephrectomy is widely practiced and has become a
67                                      After a radical nephrectomy, larger nephrons and nephrosclerosis
68 risk (pT1Nx-0) after partial (LR-partial) or radical nephrectomy (LR-radical) or as moderate/high ris
69         However, the likelihood of receiving radical nephrectomy (odds ratio [OR], 1.00; 95% CI, 0.78
70 ogressive CKD among patients who underwent a radical nephrectomy or a for-cause native kidney biopsy,
71 edly support the superiority of laparoscopic radical nephrectomy over open radical nephrectomy for th
72 tic surgery has been successfully applied to radical nephrectomy, partial nephrectomy and pyeloplasty
73                 In conclusion, compared with radical nephrectomy, partial nephrectomy was associated
74 ate cancer, or bladder cancer who received a radical nephrectomy, partial nephrectomy, radical prosta
75                                   Adjunctive radical nephrectomy, performed either before or after th
76 oved patient recovery for such procedures as radical nephrectomy, radical nephroureterectomy and dono
77           Multivariable analysis showed that radical nephrectomy remained an independent risk factor
78 omes and recent developments in laparoscopic radical nephrectomy reported over the past year.
79 4 (41.5%) patients died following partial or radical nephrectomy, respectively.
80 prediction of new baseline GFR (NBGFR) after radical nephrectomy (RN) can inform clinical management
81  outcomes after partial nephrectomy (PN) and radical nephrectomy (RN) from the National Cancer Databa
82 oaches (MIS) in partial nephrectomy (PN) and radical nephrectomy (RN), assessment of long-term cost i
83                     A total of 474 patients (radical nephrectomy [RN, n = 236] & partial nephrectomy
84 urgical procedures (radical cystectomy [RC], radical nephrectomy [RN], and radical prostatectomy [RP]
85 ement of small renal tumors is changing from radical nephrectomy to nephron-conserving surgery.
86 ence standard treatment of SRMs evolved from radical nephrectomy to nephron-sparing approaches.
87  effectiveness of partial nephrectomy versus radical nephrectomy to preserve kidney function has not
88 tely and by cortex depth in patients who had radical nephrectomy to remove a tumor from 2019 to 2020.
89  surgery, treatment with partial rather than radical nephrectomy was associated with improved surviva
90 reatments for early-stage RCC are partial or radical nephrectomy, which can result in 5-year cancer-s
91                     Therefore, whereas fewer radical nephrectomies will be performed for T1a tumors,
92 ides equivalent oncological tumor control to radical nephrectomy with maximum preservation of long-te